Search results
Pfizer's Stock Is a Buy. Here Are Six Reasons Why.
Motley Fool via Yahoo Finance· 4 hours agoPfizer (NYSE: PFE) stock is an investing enigma. The drugmaker's shares have printed fresh 52-week lows consistently over the past two years, putting its...
Albert Bourla
Time Magazine· 1 hour agoWhen Albert Bourla became CEO of Pfizer in 2019, just before the pandemic, he wanted to make Pfizer’s medicines more affordable to more patients. “No...
Pfizer beats earnings estimates months after stock dipped to record lows
Crain's New York Business· 15 hours agoWhen excluding Pfizer’s Covid products, revenues increased 11%, indicating the success of its $43 billion acquisition of oncology firm Seagen and sales of blockbuster drugs ...
Why Pfizer Stock Blasted More Than 6% Higher Today
Motley Fool via Yahoo Finance· 16 hours agoPfizer (NYSE: PFE) stock got a very effective shot in the arm on Wednesday. This was supplied by its latest earnings release, which saw the storied...
Pfizer stock gains 7% after earnings beat, company calls dividend 'secure'
Yahoo Finance via AOL· 17 hours agoPfizer also faces the expiration of patents on some of its biggest drugs, including breast cancer...
Pfizer Sees Less Revenue From Covid-19 Treatments, Stock Faces Headwinds Ahead Of Q1 Earnings - ...
Benzinga· 2 days agoPfizer's Q1 earnings report expects EPS of 49 cents and $13.09 billion in revenues. Stock has...
Pfizer earnings beat by $0.29, revenue topped estimates By Investing.com
Investing.com· 1 day agoPfizer earnings beat by $0.29, revenue topped estimates
Pfizer (PFE) Q1 Earnings and Revenues Beat Estimates
Zacks via Yahoo Finance· 1 day agoPfizer (PFE) delivered earnings and revenue surprises of 46.43% and 7.37%, respectively, for the quarter ended March 2024. Do the numbers hold clues to...
Naviter Wealth LLC Sells 3,036 Shares of Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 20 hours agoThe institutional investor owned 21,557 shares of the biopharmaceutical company’s stock after selling 3,036 shares during the period. Naviter Wealth LLC’s holdings in < ...
Pfizer’s 44% Decline In Profits Still Tops Estimates—Stock Bounces From Decade Low
Forbes· 1 day agoPfizer comfortably beat expectations in its quarterly earnings report Wednesday morning, as the...
